Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections

    Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections

    FromNeurology Minute

    Start listeningView podcast show

    Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections

    FromNeurology Minute

    ratings:
    Length:
    4 minutes
    Released:
    Mar 29, 2024
    Format:
    Podcast episode

    Description

    Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200211 
    Released:
    Mar 29, 2024
    Format:
    Podcast episode

    Titles in the series (100)

    The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD, FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.